Certified by Founder Lodge
Cytospire Therapeutics Ltd
- ND
START UP
1 Disclosed Funding Rounds $82,984,705
0 Participating Investments
-
Founded date
2023
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Cytospire Therapeutics is developing a portfolio of next generation immune cell engagers
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| May, 07 ,2026 | Series A | $82,984,705 |
Abingworth
LifeArc Ventures
4BIO Capital
British Business Bank
Sound Bioventures
Criteria Bio Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
InCharge Energy | $46,000,000 | (Jun 5, 2026)
Forage | $40,000,000 | (Jun 5, 2026)
ZutaCore | $100,000,000 | (Jun 5, 2026)
Quobly | $133,545,475 | (Jun 5, 2026)
Oak Hill Bio | $32,500,000 | (Jun 5, 2026)
